Ipsen is a French biopharmaceutical company focused on transformative medicines in oncology, rare disease, and neuroscience. It is one of the world's top 15 biopharmaceutical companies in terms of oncology sales. Founded in 1929 by Henri Beaufour, Ipsen has approximately 5,000 employees worldwide and its medicines are registered in more than 100 countries. The company is publicly traded on Euronext Paris and is family-owned, with the Beaufour family owning a majority of shares and voting rights.

Ipsen

We‘re more than a manufacturer.
When you partner with Ipsen, you get the support and rescoureces of an entire team dedicated to your success.
From sales and service, to project management, engineering, production and quality control, we are committed to delivering an exceptional customer experience.

Advanced Engineering Solutions
Ipsen‘s Engineering Team has the experience and resources to design and manufacture innovative, highly technical atmosphere and vacuum.

About us
Backed by more than 70 years of experience, our mission is to strengthen heat treatment through expert-driven solutions.
Much like our founder, Harold Ipsen, we believe that innovation drives excellence. We are committed to delivering proven technology for a range of applications that enable you to transform space exploration, improve titanium medical implants and develop more efficient cars and jet engines.
Through our global partnerships, we provide unmatched service and support for all your needs.

Find our imprint on http://www.ipsenglobal.com/en/imprint/

Ipsen International GmbH

𝟳𝟱𝘁𝗵 𝗮𝗻𝗻𝗶𝘃𝗲𝗿𝘀𝗮𝗿𝘆 𝗼𝗳 𝗜𝗽𝘀𝗲𝗻 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗚𝗺𝗯𝗛 - 𝗮 𝗱𝗮𝘆 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗲𝗺𝗽𝗹𝗼𝘆𝗲𝗲𝘀
 
Video: https://lnkd.in/e5rpJN5c
The 75th anniversary of Ipsen International GmbH was an unforgettable day for all employees. 
We started with a common breakfast and got interesting insights into heat technology and latest software developments by our colleagues 
𝗛𝗲𝗿𝗯𝗲𝗿𝘁 𝗛𝗮𝗻𝘀 𝗮𝗻𝗱 𝗔𝗿𝗻𝗱𝘁 𝗪𝗲𝘁𝘇𝗲𝗹. Then we opened together with the minister Mona Neubaur the new technical center "Future Lab" and we  received exclusive explanations about our innovations. 
 
To round off the day in a informal atmosphere, we formed groups and took part in an exciting iPad rally. Within a radius of 2 km, our teams answered questions and solved tasks. There was a lot of fun and laughter before we returned to Ipsen after 1.5 hours. The winning team was rewarded with a check worth 800€ for another team event. 
In bright sunshine, we ended the day together and all agreed: This day was a complete success and has welded us even closer together as a team.

𝗜𝗺𝗽𝗿𝗲𝘀𝘀𝗶𝗼𝗻𝘀 "𝗧𝗵𝗲 𝗘𝘃𝗲𝗻𝘁 𝗢𝗳 𝗧𝗵𝗲 𝗬𝗲𝗮𝗿 𝗶𝗻 𝗛𝗲𝗮𝘁 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁: 𝗜𝗽𝘀𝗲𝗻 -𝗠𝗲𝗲𝘁 𝘁𝗵𝗲 𝗛𝗲𝗮𝘁 𝟮𝟬𝟮𝟯”
What an incredible event! Thank you to everyone who made our Meet the Heat 2023 event such a success. We were so happy to see so many familiar faces and meet new ones too! From our amazing speakers to our dedicated attendees, we couldn't have done it without you all.

#ipsenglobal #ics #mth2023

Ipsen Meet the Heat - Podiumsdiskussion mit Prof. Dr. Dudenhöffer / Prof. Dr. Pfeifer / Paul van Doesburg und Dr Bora Özkan.

𝗙𝗶𝗿𝘀𝘁 𝗶𝗺𝗽𝗿𝗲𝘀𝘀𝗶𝗼𝗻𝘀 𝗼𝗳 𝗜𝗽𝘀𝗲𝗻 - 𝗠𝗲𝗲𝘁 𝘁𝗵𝗲 𝗛𝗲𝗮𝘁! From insightful presentations to engaging discussions, our first day at Ipsen-Event Meet the Heat 2023 left us feeling inspired and motivated!  Looking forward to seeing where this journey takes us next! 

#ipsenglobal #ics #mth2023

𝗡𝗥𝗪-𝗠𝗶𝗻𝗶𝘀𝘁𝗲𝗿𝗶𝗻 𝗠𝗼𝗻𝗮 𝗡𝗲𝘂𝗯𝗮𝘂𝗿 𝘄𝗲𝗶𝗵𝘁 𝗱𝗮𝘀 𝗙𝘂𝘁𝘂𝗿𝗲 𝗟𝗮𝗯 𝗱𝗲𝗿 𝗙𝗶𝗿𝗺𝗮 𝗜𝗽𝘀𝗲𝗻 𝗚𝗺𝗯𝗛 𝘄ä𝗵𝗿𝗲𝗻𝗱 𝗱𝗲𝗿 𝟳𝟱- 𝗷ä𝗵𝗿𝗶𝗴𝗲𝗻 𝗝𝘂𝗯𝗶𝗹ä𝘂𝗺𝘀𝗳𝗲𝗶𝗲𝗿 𝗲𝗶𝗻

Kleve: 18.09.2023 - Feierstimmung bei Ipsen International: Das Traditionsunternehmen aus Kleve lud am Montag seine Mitarbeiter und Mitarbeiterinnen zum 75-jährigen Bestehen der Firma ein. Am Mittag traf noch ein weiterer prominenter Gast ein: NRW-Wirtschaftsministerin Mona Neubaur tauschte sich mit Unternehmensvertretern über Chancen des Maschinenbaus als Enabler für den Klimaschutz aus.
Das Maschinen- und Anlagenbauunternehmen Ipsen besteht seit 1948 und ist heute eine international agierende Unternehmensgruppe, die zu den Marktführern in der Wärmebehandlungstechnik zählt. Das Unternehmen baut Industrieöfen und Anlagen zur Wärmebehandlung von Bauteilen und Komponenten und feierte sein 75-jähriges Bestehen. 
„Mit dem Ipsen Future Lab haben wir ein weltweit erstes Technikum entwickelt, in dem Hybrid-Industrieöfen präsentieren werden, die neben Propan, LPG, LNG auch zu 100 % mit Wassersoff betrieben werden können. Mit dieser neuen Generation von Wärmebehandlungsanlagen wird ein wichtiger Beitrag für den Klimaschutz und zur Verbesserung der Luftqualität geleistet. Neben der Energieeinsparung werden klima- und gesundheitsschädliche Abgase wie Kohlendioxide und Stickoxide deutlich reduziert“ so der Geschäftsführer Paul van Doesburg. 
Die Veranstaltung bot eine gute Gelegenheit für Mitarbeiterinnen und Mitarbeiter das neue Future Lab kennenzulernen. Untermauert wurde die Einweihung mit verschieden Vorträgen zur Wärmetechnik und zu den Besonderheiten des Ipsen Future Labs. 
Für das Unternehmen gehörte der Besuch von Wirtschafts- und Klimaschutzministerin Mona Neubaur zu den Höhepunkten des Tages. Die Ministerin weihte das Ipsen Future Lab ein: „Wasserstoff ist ein entscheidender Baustein für die klimaneutrale Transformation unserer Wirtschaft und ein riesiger Wachstumsmarkt und eröffnen dem Maschinen- und Anlagenbau enorme Chancen. Innovative Verfahren leisten einen entscheidenden Beitrag für klimafreundliche Industrieprozesse und stärken die Wettbewerbsfähigkeit unserer starken Maschinenbauunternehmen in Nordrhein-Westfalen. Das ist ein wichtiger Schritt auf dem Weg Nordrhein-Westfalens zum ersten klimaneutralen Industriestandort Europas.“

#IpsenGlobal #Neubaur #NRW-Ministerium #Neubaur

Technology. Innovation. Service
Werden Sie Teil unseres erfolgreichen Teams: Ihre Karriere bei Ipsen.
https://lnkd.in/essYk6z8

Ipsen - Meet the Heat 20. & 21. Sept. 2023

Registration: www.ipsen-mth2023.de/en

#ipsenglobal #mth2023 #energyefficiency #ics

𝗜𝗽𝘀𝗲𝗻 - 𝗠𝗲𝗲𝘁 𝘁𝗵𝗲 𝗛𝗲𝗮𝘁 - 𝟮𝟬. & 𝟮𝟭. 𝗦𝗲𝗽𝘁. 𝟮𝟬𝟮𝟯 the event of the year in heat treatment is reaching its full capacity of 𝟯𝟬𝟬 𝗽𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝗻𝘁𝘀. All interested attendees from the heat treatment industry who will have the privilege to see the first furnace with CO2 neutral heating system.
www.ipsen-mth2023.de\en

#ipsenglobal #ipsengermany #ics #mth2023 #energyefficiency

𝗜𝗽𝘀𝗲𝗻 - 𝗠𝗲𝗲𝘁 𝘁𝗵𝗲 𝗛𝗲𝗮𝘁 𝟮𝟬. & 𝟮𝟭. 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿 𝟮𝟬𝟮𝟯

The hottest answer to CO2-optimized heat treatment: 
Ipsen-ATLAS Green (Hybrid furnace)

Come and see: www.ipsen-mth2023.de/en

#ipsenGlobal #ics #hydrogen #heattreatment

Metric
Company Name	Ipsen
Symbol
MSH ID	DE:IPSEN
Market	PRIVATE
Sector	Healthcare
Industry	Pharmaceutical
Country	DE
Stage
Employee Count	1.00K
Website	ipsen.de
LinkedIn	ipsen-international-gmbh
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	92.20K
Web Traffic Growth	0.17
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score	72.76
28-Day Growth Score	88.97
90-Day Growth Score	89.45
365-Day Growth Score	43.26

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

DE:IPSEN

Ipsen

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue